CME webinar: Vaccination Acceptance & Addressing Today’s Challenges

Mar. 2023Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, May 17, from noon to 1 p.m. that will provide an overview of how to address vaccine acceptance. This webinar is being offered as part of the Pediatric Collaborative Call series.

During this presentation, experts will discuss:
  • The history of vaccine development, effectiveness, and attitudes.
  • Current trends in vaccination rates.
  • The challenge of vaccine hesitancy.

Presenters:
  • Andrew Nowalk, MD, PHD, Associate Professor of Pediatrics, University of Pittsburgh; Clinical Director of Infectious Diseases, UPMC Children’s Hospital of Pittsburgh; Co-Director, Pediatrics Residency Program, UPMC Children’s Hospital of Pittsburgh
  • Mary Ann Rigas, MD, FAAP, Medical Director of Pediatrics, UPMC Cole; President, Pennsylvania Chapter of the American Academy of Pediatrics
  • Todd Wolynn, MD, MMM, IBCLC, CEO—Kids Plus Pediatrics; Advisory Board President, Shots Heard Round the World
  • Deborah Moss, MD, MPH, FAAP, Professor of Pediatrics, Children’s Hospital of Pittsburgh; Pediatric Medical Director, UPMC Health Plan
  • Robert Rutkowski, MD, FAAP, Medical Director, Practice Transformation and Provider Relations, UPMC Health Plan; Co-Lead Physician, UPMC CCP Children’s Community Pediatrics, Shenango
  • Alin Severance, MD, Medical Director, Behavioral Health Services, UPMC Health Plan; Associate Medical Director, Community Care Behavioral Health Organization

Register now. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility."

Recent Announcements

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Nov. 2025Important Notices

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Nov. 2025Education/Webinars